FDA Closes Orphan Designation Loophole for Pediatric Subpopulations

Drug Industry Daily
A A
Closing what it calls an “unintended loophole,” the FDA will no longer issue orphan drug designations for smaller pediatric subpopulations of more common diseases, unless certain criteria are met.

To View This Article:

Login

Subscribe To Drug Industry Daily